From: Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India
Possible alleles shared between pairs (n/total) | Infection(s) with allele pair profile (n/total) | Maximum expected probability (SE) | Subject completing PQ treatment (n/total) |
---|---|---|---|
1/8 | 4/17 | 0.422 (0.410, 0.434) | 2/4 |
2/8 | 1/17 | 0.119 (0.11, 0.128) | 0/1 |
3/8 | 1/17 | 0.032 (0.028, 0.036) | 0/1 |
4/8 | 1/17 | 0.008 (0.007, 0.010) | 1/1 |
5/8 | 1/17 | 0.002 (0.001, 0.003) | 1/1 |
6/8 | 2/17 | 5.23E-04 (3.90E-04, 6.92E-04) | 1/2 |
7/8 | 1/17 | 1.23E-04 (8.60E-04, 1.72E-04) | 1/1 |
8/8 | 6/17 | 2.68E-05 (1.76E-05, 4.00E-05) | 4/6 |